Lime Chemicals (BSE 507759)₹14.75+9.34%Commodity Chemicals
In the Mar 2026 quarter (standalone), Lime Chemicals reported sales of ₹2.29 Cr, up 38.8% from Mar 2025, and net profit of ₹0.04 Cr, down 42.9% year on year. For the year to Mar 2026, sales were ₹7.14 Cr and net profit −₹0.18 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.26 | 2.26 | 2.60 | 2.37 | 3.05 | 2.39 | 2.61 | 1.65 | 1.86 | 1.47 | 1.54 | 2.29 |
| Expenses | 3.53 | 2.37 | 2.83 | 2.46 | 2.90 | 2.43 | 2.55 | 1.88 | 2.00 | 1.62 | 1.61 | 2.32 |
| Operating Profit | −0.30 | −0.14 | −0.26 | −0.12 | 0.14 | −0.07 | 0.05 | −0.26 | −0.17 | −0.18 | −0.10 | −0.06 |
| OPM % | −9.0% | −5.8% | −9.7% | −4.7% | 4.3% | −2.5% | 1.5% | −15.3% | −8.7% | −11.7% | −5.9% | −2.2% |
| Other Income | 0.11 | 0.05 | 0.22 | 0.06 | 0.05 | 0.04 | 0.05 | 0.50 | 0.23 | 0.04 | 0.04 | 0.13 |
| Interest | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.03 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit before tax | −0.20 | −0.10 | −0.05 | −0.09 | 0.14 | −0.04 | 0.05 | 0.06 | 0.03 | −0.15 | −0.07 | 0.02 |
| Tax % | 0.0% | 0.0% | 0.0% | 10.0% | 0.0% | 0.0% | 0.0% | 28.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.22 | −0.12 | −0.07 | −0.12 | 0.16 | −0.06 | 0.07 | 0.07 | 0.04 | −0.17 | −0.09 | 0.04 |
| EPS (Rs) | −0.31 | −0.16 | −0.08 | −0.16 | 0.22 | −0.07 | 0.08 | 0.08 | 0.04 | −0.26 | −0.11 | 0.04 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.24 | 43.95 | 51.78 | 43.54 | 31.29 | 22.26 | 14.10 | 15.52 | 10.48 | 9.69 | 7.14 | 7.16 |
| Expenses | 24.09 | 36.60 | 43.07 | 39.92 | 30.76 | 21.57 | 14.74 | 15.29 | 11.18 | 9.80 | 7.57 | 7.55 |
| Operating Profit | 4.03 | 7.24 | 8.49 | 3.49 | 0.43 | 0.59 | −0.71 | 0.19 | −0.75 | −0.15 | −0.47 | −0.51 |
| OPM % | 14.2% | 16.4% | 16.3% | 8.0% | 1.3% | 2.6% | −5.0% | 1.2% | −7.1% | −1.5% | −6.5% | −7.1% |
| Other Income | 0.41 | 0.16 | 0.56 | 0.90 | 0.69 | 1.26 | 10.98 | 3.22 | 0.40 | 0.62 | 0.41 | 0.44 |
| Interest | 0.23 | 0.53 | 0.35 | 0.74 | 1.47 | 0.59 | 0.22 | 0.10 | 0.05 | 0.16 | 0.04 | 0.03 |
| Depreciation | 0.70 | 2.18 | 1.03 | 1.03 | 1.13 | 1.06 | 0.27 | 0.23 | 0.10 | 0.09 | 0.09 | 0.12 |
| Profit before tax | 3.50 | 4.66 | 7.63 | 2.61 | −1.47 | 0.19 | 9.77 | 3.07 | −0.47 | 0.23 | −0.16 | −0.17 |
| Tax % | 6.5% | −8.0% | 0.0% | 0.0% | −78.4% | 30.0% | 0.0% | 10.4% | 2.1% | 8.3% | 0.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 10.95 | 2.99 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 3.28 | 5.06 | 7.68 | 2.63 | −0.33 | 0.15 | 9.84 | 2.77 | −0.50 | 0.23 | −0.18 | −0.18 |
| EPS (Rs) | 9.93 | 15.31 | 15.68 | 4.02 | −0.48 | 0.21 | 15.05 | 4.23 | −0.74 | 0.33 | −0.25 | −0.29 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.27 | 3.27 | 3.27 | 4.89 | 6.52 | 6.52 | 6.52 | 6.52 | 6.51 | 6.52 | 6.51 | 6.52 |
| Reserves | −40.04 | −36.77 | −31.90 | −21.02 | −16.78 | −17.07 | −16.78 | −7.02 | −4.32 | −4.75 | −4.55 | −4.69 |
| Borrowings | 30.56 | 31.83 | 29.85 | 27.72 | 15.76 | 13.37 | 12.00 | 7.47 | 5.73 | 5.02 | 5.11 | 4.76 |
| Other Liabilities | 24.23 | 21.51 | 27.33 | 22.48 | 18.38 | 21.23 | 12.96 | 10.57 | 5.20 | 3.87 | 3.03 | 7.08 |
| Total Liabilities | 18.02 | 19.84 | 28.55 | 34.07 | 23.88 | 24.05 | 14.70 | 17.54 | 13.12 | 10.66 | 10.10 | 13.67 |
| Fixed Assets | 10.40 | 10.75 | 8.93 | 9.23 | 8.95 | 8.57 | 2.58 | 6.21 | 5.77 | 5.70 | 5.74 | 5.67 |
| CWIP | 0.19 | 0.15 | 0.76 | 0.00 | 0.06 | 0.12 | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.02 | 0.04 | 0.10 | 0.12 | 0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 |
| Other Assets | 7.41 | 8.92 | 18.82 | 24.74 | 14.75 | 15.25 | 10.05 | 11.22 | 7.23 | 4.84 | 4.24 | 7.88 |
| Inventories | 1.53 | 1.82 | 2.57 | 4.22 | 4.71 | 3.73 | 1.46 | 0.39 | 1.25 | 0.38 | 0.14 | 4.43 |
| Trade receivables | 2.92 | 4.74 | 11.58 | 17.93 | 7.55 | 8.67 | 4.40 | 6.56 | 3.66 | 2.34 | 1.84 | 1.63 |
| Cash & equivalents | 0.28 | 0.48 | 3.21 | 0.70 | 1.00 | 0.63 | 0.42 | 0.38 | 0.43 | 0.29 | 0.14 | 0.36 |
| Total Assets | 18.02 | 19.84 | 28.55 | 34.07 | 23.88 | 24.05 | 14.70 | 17.54 | 13.12 | 10.66 | 10.10 | 13.67 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −3.94 | 0.17 | 4.19 | −6.72 | 8.70 | 3.30 | 1.71 | −5.29 | −2.62 | 0.54 | −0.22 | 0.54 |
| Cash from investing activity | −0.76 | −1.00 | −1.04 | −0.56 | −0.68 | −0.91 | −0.05 | 9.96 | 4.38 | 0.03 | −0.07 | 0.05 |
| Cash from financing activity | 4.63 | 1.05 | −0.44 | 4.79 | −7.74 | −2.94 | −1.92 | −4.53 | −1.69 | −0.70 | 0.12 | −0.37 |
| Net cash flow | −0.06 | 0.20 | 2.71 | −2.50 | 0.29 | −0.53 | −0.22 | 0.13 | 0.04 | −0.13 | −0.14 | 0.21 |
| Capex | 0.80 | 1.00 | 1.08 | 0.56 | 0.76 | 0.77 | 0.03 | 2.03 | 0.00 | 0.02 | 0.10 | 0.01 |
| Free cash flow | −4.77 | −0.84 | 3.10 | −7.29 | 7.91 | 2.50 | 1.69 | −7.31 | −2.11 | 0.49 | −0.33 | 0.50 |
| CFO / OP % | 439.1% | 4.0% | 58.1% | −80.0% | 260.1% | 710.1% | 309.1% | 734.0% | −1,394.0% | −88.9% | 129.1% | −124.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 57 | 63 | 97 | 128 | 65 | 102 | 74 | 172 | 88 | 82 | 70 | 84 |
| Inventory days | 54 | 44 | 40 | 58 | 70 | 80 | 40 | 16 | 41 | 19 | 9 | 300 |
| Days payable | 161 | 116 | 238 | 204 | 182 | 274 | 153 | 190 | 135 | 142 | 138 | 433 |
| Cash conversion cycle | −53 | −13 | −104 | −21 | −50 | −94 | −43 | −5 | −9 | −44 | −62 | −53 |
| Working capital days | −181 | −69 | −332 | −173 | −143 | −224 | −254 | −109 | −104 | −168 | −165 | −243 |
| ROCE % | — | — | — | 124.6% | 38.5% | −0.7% | 87.9% | −18.5% | 1.1% | −5.9% | 5.6% | −2.0% |
For the Mar 2026 quarter, Lime Chemicals reported sales of ₹2.29 Cr, up 38.8% year on year and net profit of ₹0.04 Cr, down 42.9% year on year. The operating margin was −2.2%.
Lime Chemicals' sales for the year to Mar 2026 were ₹7.14 Cr; over the last twelve months they were ₹7.16 Cr.
Net profit for the year to Mar 2026 was −₹0.18 Cr, and −₹0.18 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.29.
Lime Chemicals reported borrowings of ₹4.76 Cr at Mar 2026, against cash and equivalents of ₹0.36 Cr.
Cash from operations was ₹0.54 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.50 Cr.